Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01361672 · ClinicalTrials.gov registry record
Model 4296 Left Ventricular (LV) Lead Chronic Performance Study
A clinical trial, sponsored by Medtronic.
- Completed
- Registry status
- 1,140
- Enrollment target
NCT01361672: Completed study, sponsored by Medtronic.
NCT01361672 is a clinical trial that has completed, run by Medtronic. The registered enrollment target is 1,140 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01361672 has completed, sponsored by Medtronic.
- COMPLETED
- Registry status
- 1,140 participants
- Enrollment target
Study Summary
Lead survivability will be summarized.
Primary Outcome
To demonstrate that the Model 4296 lead-related complication-free probability
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,140 participants |
| Start Date | 2011-05 |
| Est. Completion | 2019-07 |
What the finished NCT01361672 record still lists
NCT01361672 is an observational study that tracks outcomes without assigning an intervention. Its 1,140 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01361672 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01361672 about?
NCT01361672 is a clinical study titled "Model 4296 Left Ventricular (LV) Lead Chronic Performance Study". Lead survivability will be summarized.
What is the current status of trial NCT01361672?
This trial is currently completed. The enrollment target is 1,140 participants. The study started on 2011-05. Estimated completion is 2019-07.
Who is sponsoring clinical trial NCT01361672?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05894967 · 1,140 participants · NA
Moderators and Mediators of Perceptual Learning
- NCT06532487 · 1,140 participants · NA
Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities
- NCT06129864 · 1,145 participants · Phase 3
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
- NCT06676319 · 1,147 participants · Phase 2
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia